Merit Financial Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Merit Financial Group's BMY Position: Q3 2026 in Review
Merit Financial Group reduced its Bristol-Myers Squibb (BMY) stake by 53% in Q3 2026, selling an estimated $12.9M and leaving 182,279 shares worth $11.4M. The position accounts for 0.06% of the portfolio, ranked #253.
Merit Financial Group first reported a position in BMY in Q4 2019 and has held it in 28 quarters since. The position peaked at $22.4M in Q1 2026. 2,561 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Merit Financial Group held 182,279 shares of Bristol-Myers Squibb worth $11.4M as of Q3 2026.
- Merit Financial Group sold 204,909 Bristol-Myers Squibb shares in Q3 2026, an estimated $12.9M.
- Bristol-Myers Squibb made up 0.06% of Merit Financial Group's portfolio in Q3 2026, its #253 holding.
- Merit Financial Group first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 28 quarters since.
- Merit Financial Group's Bristol-Myers Squibb position peaked at $22.4M in Q1 2026.
- 2,561 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Merit Financial Group's 13F filing for Q3 2026, filed 6 Nov 2026.